Xencor Inc. diskutieren
Xencor Inc.
WKN: A1W96L / Symbol: XNCR / Name: Xencor / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
22,60 €
-0,89 %
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at SVB Leerink LLC.
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Wedbush from $37.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Royal Bank of Canada from $36.00 to $32.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Guggenheim from $40.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Mizuho from $59.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at Wedbush from $36.00 to $34.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at BMO Capital Markets from $38.00 to $34.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target lowered by analysts at BTIG Research from $56.00 to $38.00. They now have a "buy" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor, Inc. (NASDAQ: XNCR) had its price target raised by analysts at Wedbush from $34.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Neueste Beiträge
Fox_i in Fox Corp. B diskutieren